Literature DB >> 29088325

Increase of programmed death ligand 1 in non-small-cell lung cancers with chronic hepatitis B.

G Lin1, W Zhuang1, X H Chen2, C Huang1, X D Lin3, Y J Huang1, C Li4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29088325     DOI： 10.1093/annonc/mdx694

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy.

Authors:  Xuanye Zhang; Dan Tian; Yue Chen; Chen Chen; Li-Na He; Yixin Zhou; Haifeng Li; Zuan Lin; Tao Chen; Yuhong Wang; Alessandro Russo; Ernest Nadal; Francesco Passiglia; Ross Andrew Soo; Satoshi Watanabe; Teresa Moran; In-Jae Oh; Sha Fu; Shaodong Hong; Li Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-07

2.  Hepatitis B virus infection does not affect the clinical outcome of anti-programmed death receptor-1 therapy in advanced solid malignancies: Real-world evidence from a retrospective study using propensity score matching.

Authors:  Liting Zhong; PinShun Zhong; Huafeng Liu; Zelei Li; Qihong Nie; Weiwei Peng
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.